Items where authors include "Hodgson, Robert"

Article

Walton, Matthew James orcid.org/0000-0003-1932-3689, Deng, Nyanar J, Corbett, Mark Stephen orcid.org/0000-0002-5937-1493 et al. (7 more authors) (2025) Re-anchoring the value of innovative therapies in NICE decision making when comparators are cost-ineffective:A case study of late-onset Pompe disease. PharmacoEconomics. ISSN 1179-2027

Walton, Matthew James orcid.org/0000-0003-1932-3689, Deng, Jasmine, Corbett, Mark Stephen orcid.org/0000-0002-5937-1493 et al. (7 more authors) (2025) The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS. European Journal of Health Economics. ISSN 1618-7601 (In Press)

Haigh, Joseph Edward, Patel, Karan, Shepherd, Lucy et al. (8 more authors) (2025) Association of quality of life with mortality in patients with adenoid cystic carcinoma using an internationally-validated QoL questionnaire (EQ-5D-5L). Oral oncology. 107584. ISSN 1368-8375

Corbett, Mark Stephen orcid.org/0000-0002-5937-1493, Umemneku-Chikere, Chinyereugo, Nevitt, Sarah Jane orcid.org/0000-0001-9988-2709 et al. (7 more authors) (2025) Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease:A systematic review and network meta-analysis. Orphanet Journal of Rare Diseases. 451. ISSN 1750-1172

Nevitt, Sarah Jane orcid.org/0000-0001-9988-2709, Phillippo, David M., Hodgson, Robert orcid.org/0000-0001-6962-2893 et al. (2 more authors) (2025) Application of Multilevel Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukaemia: an External Assessment Group perspective. PharmacoEconomics. pp. 243-247. ISSN 1179-2027

Hodgson, Robert orcid.org/0000-0001-6962-2893, Walton, Matthew James orcid.org/0000-0003-1932-3689, Fulbright, Helen Athena et al. (9 more authors) (2025) A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy. Health technology assessment. pp. 165-184. ISSN 2046-4924

Simmonds, Mark Crawford orcid.org/0000-0002-1999-8515, Llewellyn, Alexis orcid.org/0000-0003-4569-5136, Walker, Ruth Alice Elizabeth orcid.org/0000-0003-2765-7363 et al. (9 more authors) (2024) Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy:a systematic review and meta-analysis. Health technology assessment. pp. 1-71. ISSN 2046-4924

Cox, Edward Miles, Wade, Ros orcid.org/0000-0002-8666-8110, Hodgson, Robert orcid.org/0000-0001-6962-2893 et al. (5 more authors) (2024) Devices for remote continuous monitoring of people with Parkinson's disease:a systematic review and cost-effectiveness analysis. Health technology assessment. pp. 1-187. ISSN 2046-4924

Walton, Matthew orcid.org/0000-0003-1932-3689, Bojke, Laura orcid.org/0000-0001-7921-9109, Simmonds, Mark orcid.org/0000-0002-1999-8515 et al. (10 more authors) (2024) Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy:A Cost-Effectiveness Analysis. Value in Health. pp. 907-917. ISSN 1524-4733

Njoroge, Martin Wanyoike orcid.org/0000-0002-9474-8698, Walton, Matthew James orcid.org/0000-0003-1932-3689 and Hodgson, Robert orcid.org/0000-0001-6962-2893 (2024) Understanding the NICE severity premium:Exploring its implementation and the implications for decision-making and patient access. Value in Health. 730 - 736. ISSN 1524-4733

Simmonds, Mark Crawford orcid.org/0000-0002-1999-8515, Llewellyn, Alexis orcid.org/0000-0003-4569-5136, Walker, Ruth Alice Elizabeth orcid.org/0000-0003-2765-7363 et al. (12 more authors) (2024) Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy:a systematic review and IPD meta-analysis. Value in Health. ISSN 1524-4733

Wade, Ros orcid.org/0000-0002-8666-8110, South, Emily orcid.org/0000-0003-2187-4762, Anwer, Sumayya orcid.org/0000-0002-1740-0399 et al. (9 more authors) (2023) Ablative and non-surgical therapies for early and very early hepatocellular carcinoma:a systematic review and network meta-analysis. Health technology assessment (Winchester, England). pp. 1-172. ISSN 2046-4924

Walton, Matthew orcid.org/0000-0003-1932-3689, Hodgson, Robert orcid.org/0000-0001-6962-2893, Eastwood, Alison orcid.org/0000-0003-1079-7781 et al. (7 more authors) (2022) Management of sudden onset severe headache patients presenting to the emergency Department:systematic review of diagnostic accuracy studies. Emergency Medicine Journal. pp. 818-825. ISSN 1472-0205

Beresford, Lucy, Murphy, Peter, Dias, Sofia orcid.org/0000-0002-2172-0221 et al. (7 more authors) (2022) Appraising the Costs of Genomic Testing for Histology-Independent Technologies:An Illustrative Example for NTRK Fusions. Value in Health. pp. 1133-1140. ISSN 1524-4733

Murphy, Peter James, Glynn, David orcid.org/0000-0002-0989-1984, Dias, Sofia orcid.org/0000-0002-2172-0221 et al. (4 more authors) (2022) Modelling approaches for histology-independent cancer drugs to inform NICE appraisals. Health technology assessment. ISSN 2046-4924

Rodgers, Mark orcid.org/0000-0002-5196-9239, Simmonds, Mark orcid.org/0000-0002-1999-8515, Marshall, David orcid.org/0000-0001-5969-9539 et al. (14 more authors) (2021) Intensive behavioural interventions based on applied behaviour analysis for young children with autism:an international collaborative individual participant data meta-analysis. Autism. 1137–1153. ISSN 1461-7005

Murphy, Peter James, Claxton, Lindsay orcid.org/0000-0002-1795-7568, Hodgson, Robert orcid.org/0000-0001-6962-2893 et al. (6 more authors) (2021) Exploring Heterogeneity in Histology-Independent Technologies and the Implications for Cost-Effectiveness. Medical Decision Making. pp. 165-178. ISSN 1552-681X

Walton, Matthew James orcid.org/0000-0003-1932-3689, Wade, Ros orcid.org/0000-0002-8666-8110, Claxton, Lindsay orcid.org/0000-0002-1795-7568 et al. (6 more authors) (2020) Selective internal radiation therapies for unresectable early-, intermediate or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation. Health Technology Asssessment. ISSN 2046-4924

Wade, Ros orcid.org/0000-0002-8666-8110, Sharif, Sahar, Harden, Melissa et al. (4 more authors) (2020) Methods for selecting the best evidence to inform a NICE technology appraisal on selective internal radiation therapies for hepatocellular carcinoma. Systematic Reviews. 184. ISSN 2046-4053

Rodgers, Mark orcid.org/0000-0002-5196-9239, Marshall, David orcid.org/0000-0001-5969-9539, Simmonds, Mark orcid.org/0000-0002-1999-8515 et al. (7 more authors) (2020) Interventions based on early intensive applied behaviour analysis for autistic children:A systematic review and cost-effectiveness analysis. Health technology assessment (Winchester, England). pp. 1-306. ISSN 2046-4924

Walton, Matthew orcid.org/0000-0003-1932-3689, Sharif, Sahar, Simmonds, Mark orcid.org/0000-0002-1999-8515 et al. (2 more authors) (2019) Tisagenlecleucel for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia in People Aged up to 25 Years:An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1209-1217. ISSN 1179-2027

Walton, Matthew James orcid.org/0000-0003-1932-3689, O'Connor, Joanne orcid.org/0000-0002-8987-0381, Carroll, Christopher et al. (2 more authors) (2019) A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process. PharmacoEconomics - Open. ISSN 2509-4254

Dickson, Rumona, Boland, Angela, Duarte, Rui et al. (16 more authors) (2018) EMA and NICE Appraisal Processes for Cancer Drugs:Current Status and Uncertainties. Applied Health Economics and Health Policy. pp. 429-432. ISSN 1175-5652

Hodgson, Robert orcid.org/0000-0001-6962-2893, Walton, Matthew orcid.org/0000-0003-1932-3689, Biswas, Mousumi orcid.org/0000-0001-6781-7400 et al. (2 more authors) (2017) Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy:An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1-12. ISSN 1179-2027

Hodgson, Robert orcid.org/0000-0001-6962-2893, Reason, Timothy, Trueman, David et al. (6 more authors) (2017) Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration:A Novel Regression Analysis to Capture the Bilateral Nature of the Disease. Advances in therapy. pp. 2360-2370. ISSN 1865-8652

Woolacott, Nerys orcid.org/0000-0003-1562-8311, Corbett, Mark orcid.org/0000-0002-5937-1493, Jones-Diette, Julie orcid.org/0000-0003-1769-8612 et al. (1 more author) (2017) Methodological challenges identified for the evaluation of clinical effectiveness in the context of accelerated regulatory approval:an overview. Journal of Clinical Epidemiology. pp. 1-25. ISSN 0895-4356

Morgan, Philip James, Woolacott, Nerys Frances orcid.org/0000-0003-1562-8311, Biswas, Mousumi orcid.org/0000-0001-6781-7400 et al. (3 more authors) (2017) Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer:An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1-11. ISSN 1179-2027

Barkovic-Parsons, Caladan, Hodgson, Robert orcid.org/0000-0001-6962-2893 and Maloney, John (2017) Are marginals different? Evidence from British elections 1950–2015. Public Choice. pp. 1-19. ISSN 1573-7101

Hettle, Robert, Corbett, Mark orcid.org/0000-0002-5937-1493, Hinde, Sebastian orcid.org/0000-0002-7117-4142 et al. (4 more authors) (2017) The assessment and appraisal of regenerative medicines and cell therapy products:an exploration of methods for review, economic evaluation and appraisal. Health technology assessment. pp. 1-204. ISSN 2046-4924

Wade, Rosalind Fay orcid.org/0000-0002-8666-8110, Hodgson, Robert orcid.org/0000-0001-6962-2893, Biswas, Mousumi orcid.org/0000-0001-6781-7400 et al. (2 more authors) (2017) A Review of Ruxolitinib for the Treatment of Myelofibrosis:A Critique of the Evidence. PharmacoEconomics. pp. 203-213. ISSN 1179-2027

Claxton,, Lindsay orcid.org/0000-0002-1795-7568, Hodgson, Robert orcid.org/0000-0001-6962-2893, Malcom, William et al. (2 more authors) (2016) Simulation Modelling in Ophthalmology:Application to Cost Effectiveness of Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration in the United Kingdom. PharmacoEconomics. pp. 1-12. ISSN 1179-2027

Hodgson, Robert orcid.org/0000-0001-6962-2893, Heywang-Köbrunnerb, Sylvia, Harvey, Susan et al. (4 more authors) (2016) Systematic review of 3D mammography for breast cancer screening. The Breast. pp. 52-61.

Lobotesis, Kyriakos, Veltkamp, Roland, Carpenter, Isobel et al. (3 more authors) (2016) Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK. Journal of Medical Economics. pp. 785-794. ISSN 941-837X

Susan, Lockyer, Hodgson, Robert orcid.org/0000-0001-6962-2893, Dumville, Joanne Clare et al. (1 more author) (2013) "Spin" in wound care research:the reporting and interpretation of randomized controlled trials with statistically non-significant primary outcome results or unspecified primary outcomes. Trials. p. 371. ISSN 1745-6215